To further investigate the involvement of HDAC11 in the pathogenesis of MASLD, RNA‐seq was performed on HepG2 cells with HDAC11 knockdown following FFA treatment. Here, HDAC11 is linked to metabolic dysfunction-associated steatotic liver disease.